Medical Communications

Showing 15 posts of 6408 posts found.

shutterstock_211705468

US annual spending on drugs rose 12.2% in 2015 – IMS

April 15, 2016 Medical Communications, Research and Development, Sales and Marketing IMS Health, drug spending

The total US spending on prescription drugs rose 12.2% to almost $425 billion in 2015 on the back of new …
cancer_cells

Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer

April 15, 2016 Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university

Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …
clinical_trial_4

Synta Pharmaceuticals announces merger with Madrigal

April 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Phase II, Synta, madrigal, merger

Synta Pharmaceuticals (NASDAQ: SNTA) has announced a definitive merger agreement with Madrigal Pharmaceuticals under which the newly-formed company will focus …
mr058666-web

Merck appoints Maya Martinez-Davis as global head of oncology

April 14, 2016 Medical Communications Merck, maya martinez-davis, oncology

Merck has announced the appointment of Maya Martinez-Davis as the new global head of oncology at the German-based company. In …
aedes_aegypti_mosquito

Zika causes microcephaly and other birth defects, says CDC

April 14, 2016 Medical Communications, Research and Development CDC, Zika, Zika virus, birth defects, microcephaly

The US Centers for Disease Control and Prevention has concluded that the Zika virus is a cause of microcephaly and …

NICE issues new guidance on the safer use of controlled drugs

April 13, 2016 Medical Communications NICE, controlled drugs, guidance

The National Institute for Health and Care Excellence (NICE) has issued guidance bringing together legislation and existing advice on the …
fda_logo-web

US FDA committee recommends against fast-track approval of Clovis’ cancer drug, asks for more data

April 13, 2016 Medical Communications, Research and Development

Shares in Clovis Oncology Inc (Nasdaq: CLVS) closed down 5.4% Tuesday after the US Food and Drug Administration advisory committee recommended …
iqwigsmall

IQWiG says Gilead’s anti-HIV drug genvoya offers slightly lower benefits than competition

April 11, 2016 Medical Communications, Research and Development Bristol-Myers Squibb, Gilead, HIV, anti-HIV

German Institute for Quality and Efficiency in Health Care (IQWiG) said USdrug maker Gilead’s (Nasdaq: GILD) anti-HIV drug Genvoya provides marginally …
handshake

Former US CEO of Boehringer Ingelheim becomes chairman at Inotek Pharmaceuticals

April 11, 2016 Medical Communications Boehringer Ingelheim, inotek, inotek pharma, j martin carroll

Inotek Pharmaceuticals has announced the appointment of J. Martin Carroll as the new chairman of the board. Carroll will succeed …
celgene-logo

Celgene says disappointed with NICE decision to not back blood cancer drug

April 8, 2016 Business Services, Medical Communications, Sales and Marketing

US drugmaker Celgene Corp (Nasdaq: CELG) on Friday said it is disappointed with UK regulators’ decision to not recommend Vidaza …
fda2outsideweb

US panel supports accelerated approval for Intercept’s trial drug for rare liver condition

April 8, 2016 Medical Communications, Research and Development, Sales and Marketing Intercept Pharmaceuticals, PDUFA, US FDA, liver disorder, rare disease

Intercept Pharmaceuticals (Nasdaq: ICPT) said a US Food and Drug Administration (FDA) advisory committee has recommended accelerated approval for its …

Pfizer, IBM partner to develop monitoring system for Parkinson’s disease

April 8, 2016 Medical Communications, Research and Development Parkinson's disease, Pfizer, collaboration, ibm, research, technology

US pharma giant Pfizer (NYSE: PFE) and International Business Machines Corp (NYSE: IBM) have partnered on a research project focussed on …
pharma_pill_manufacturing

AstraZeneca and Eli Lilly to enter Phase III on Alzheimer’s clinical trials

April 8, 2016 Medical Communications AZD3293, Alzheimer's, Alzheimers, AstraZeneca, amaranth, clinical trial, lilly, phase III

AstraZeneca and Eli Lilly have announced the continuation of their clinical trial for people with early Alzheimer’s disease into Phase …
apps_mobile

FTC launches tool to help mobile health app developers determine applicable regulations

April 8, 2016 Medical Communications, Sales and Marketing FDA, FTC, apps, health, health apps, regulation

The US Federal Trade Commission has created a new web-based tool for developers of health-related mobile apps to help them …

Vectura to get $10 million milestone as Hikma files ANDA for generic copy of GSK’s asthma drug

April 8, 2016 Medical Communications, Research and Development, Sales and Marketing

Vectura Group (LSE: VEC) on Friday said it is set to receive $10 million in milestone payments from partner Hikma …
The Gateway to Local Adoption Series

Latest content